Prostaglandins modulate platelet aggregation, kidney function, immune responses, respiratory function, reproduction and other physiological processes. Abnormalities of prostaglandin biosynthesis occur in pain, fever, bone resorption, cardiovascular disease, inflammation and cancer. Cyclooxygenase/prostaglandin synthase (COX/PGS) catalyzes the synthesis of the common intermediate, PGH2, in the production of prostaglandins. We identified a second, inducible COX, COX-2. We also demonstrated that COX-2 induction is required for prostaglandin production in response to growth factors and inflammatory stimuli, a result that provides the rationale for the clinical utility of COX-2 specific inhibitors. Elevated COX-2 gene expression plays a role in many pathologies. The ability to measure COX-2 expression in living animals would permit us to (i) determine the role of COX-2 in inflammatory responses and tumor progression and (ii) evaluate the utility of monitoring COX-2 expression as an intermediary marker of both disease and therapeutic response. We developed methods to measure reporter gene expression repetitively, non-invasively and quantitatively in living animals. We express reporter genes whose protein products sequester positron-labeled probes, then detect reporter gene-dependent probe retention by using positron emission tomography (PET). We have developed two systems; (i) Herpes Simplex Virus 1 thymidine kinase (HSV1-tk) as the """"""""PET reporter gene"""""""" and [18F]-8-acycloguanosines (ganciclovir, penciclovir) as the """"""""PET reporter probes"""""""", and (ii) the dopamine D2 receptor (D2R) as the PET reporter gene and [18F] fluoroethylspiperone as the PET reporter probe. We validated these two PET reporter gene systems in both a somatic viral delivery model and in transplantable tumor models. We will develop procedures to quantitatively and non-invasively monitor PET reporter gene expression from COX-2 promoter-driven transgenes and from the endogenous COX-2 gene. We will create transgenic and """"""""knock-in"""""""" mice in which the HSV1-tk and D2R PET reporter probes to monitor COX-2 gene expression in four inflammation models (the carageenan-injected paw, air-pouch inflammation and liver inflammation) and in two tumor induction systems [multi-stage initiation-promotion- progression skin carcinogenesis and intestinal neoplasia in min1(+/- )mice]. These mice will permit investigators to monitor COX-2 expression in a variety of paradigms.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA084572-01
Application #
6051603
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Menkens, Anne E
Project Start
1999-12-17
Project End
2004-11-30
Budget Start
1999-12-17
Budget End
2000-11-30
Support Year
1
Fiscal Year
2000
Total Cost
$314,620
Indirect Cost
Name
University of California Los Angeles
Department
Pharmacology
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Cherukuri, Durga P; Ishikawa, Tomo-O; Chun, Patrick et al. (2014) Targeted Cox2 gene deletion in intestinal epithelial cells decreases tumorigenesis in female, but not male, ApcMin/+ mice. Mol Oncol 8:169-77
Hill, Reginald; Li, Yunfeng; Tran, Linh M et al. (2012) Cell intrinsic role of COX-2 in pancreatic cancer development. Mol Cancer Ther 11:2127-37
Ishikawa, Tomo-o; Herschman, Harvey R (2011) Conditional bicistronic Cre reporter line expressing both firefly luciferase and ?-galactosidase. Mol Imaging Biol 13:284-92
Streicher, John M; Ren, Shuxun; Herschman, Harvey et al. (2010) MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ Res 106:1434-43
Streicher, John M; Kamei, Kenichiro; Ishikawa, Tomo-o et al. (2010) Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice. J Mol Cell Cardiol 49:88-94
Ishikawa, Tomo-o; Jain, Naveen K; Herschman, Harvey R (2010) Cox-2 gene expression in chemically induced skin papillomas cannot predict subsequent tumor fate. Mol Oncol 4:347-56
Ishikawa, Tomo-O; Herschman, Harvey R (2010) Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis 31:729-36
Ishikawa, Tomo-O; Kumar, Indracanti Prem; Machado, Hidevaldo B et al. (2010) Positron emission tomography imaging of DMBA/TPA mouse skin multi-step tumorigenesis. Mol Oncol 4:119-25
Ishikawa, Tomo-O; Jain, Naveen; Herschman, Harvey R (2009) Feedback regulation of cyclooxygenase-2 transcription ex vivo and in vivo. Biochem Biophys Res Commun 378:534-8
Zaiss, Anne K; Machado, Hidevaldo B; Herschman, Harvey R (2009) The influence of innate and pre-existing immunity on adenovirus therapy. J Cell Biochem 108:778-90

Showing the most recent 10 out of 30 publications